Market Overview - The agricultural chemical sector experienced a decline of 1.98% on September 18, with LuHua Technology leading the drop [1] - The Shanghai Composite Index closed at 3831.66, down 1.15%, while the Shenzhen Component Index closed at 13075.66, down 1.06% [1] Stock Performance - Notable gainers in the agricultural chemical sector included: - BaiAo Chemical (603360) with a closing price of 25.43, up 2.21% on a trading volume of 251,300 shares and a turnover of 644 million yuan [1] - Jinzhengda (002470) closed at 1.93, up 1.58% with a trading volume of 1,711,800 shares and a turnover of 333 million yuan [1] - Major decliners included: - LuHua Technology (600691) which fell by 5.16% to a closing price of 2.94, with a trading volume of 1,250,400 shares and a turnover of 376 million yuan [2] - Dongfang Tower (002545) decreased by 4.94% to 13.29, with a trading volume of 502,100 shares and a turnover of 673 million yuan [2] Capital Flow - The agricultural chemical sector saw a net outflow of 962 million yuan from institutional investors, while retail investors contributed a net inflow of 539 million yuan [2] - The sector's capital flow indicates a mixed sentiment, with institutional investors withdrawing funds while retail investors increased their positions [2] Individual Stock Capital Flow - BaTian Co. (002170) had a net inflow of 47.74 million yuan from institutional investors, representing 12.90% of its trading volume [3] - New安股份 (600596) experienced a net inflow of 16.36 million yuan from institutional investors, accounting for 5.54% of its trading volume [3] - In contrast, 富邦科技 (300387) saw a net outflow of 15.66 million yuan from retail investors, indicating a potential shift in investor sentiment [3]

Core Viewpoint - The company, Si Er Te, is currently under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws, which may lead to potential compensation claims from affected investors [3]. Group 1: Financing Activities - On September 15, Si Er Te had a financing buy-in of 7.175 million yuan, with a financing repayment of 3.619 million yuan, resulting in a net financing buy of 3.556 million yuan. This marks a cumulative net buy of 22.022 million yuan over the past five days [2]. Group 2: Regulatory Actions - On September 1, Si Er Te received a notice from the CSRC regarding an investigation into the company for suspected information disclosure violations, which could lead to legal consequences under relevant laws [3]. - Affected investors who purchased shares between April 20, 2022, and April 25, 2025, and held them until the latter date may be eligible for compensation claims [3]. Group 3: Accounting Policy Changes - On April 30, Si Er Te announced a change in accounting policies in accordance with the Ministry of Finance's new guidelines, which does not require board or shareholder approval [4]. - The company stated that the accounting policy change will not affect previously disclosed financial statements and will not have a significant impact on its financial status, operating results, or cash flows [5].

Group 1 - Yihau New Materials plans to reduce its shareholding by up to 1% of the company's total shares, amounting to 165,500 shares, due to personal funding needs [1] - Fuxing Pharmaceutical's subsidiary has received approval for a new indication for its drug, which is used in the treatment of certain types of breast cancer [1][2] - Shantui Co. has submitted its H-share issuance application to the China Securities Regulatory Commission, which has been accepted [3] Group 2 - Sierte's chairman plans to increase his shareholding by an amount between 3 million to 6 million yuan [4] - Borui Pharmaceutical's BGM0504 tablet has received approval for clinical trials in overweight and obese adults [5] - Ganyue Expressway reported vehicle toll service revenue of 349 million yuan for August [6] Group 3 - Chip Microelectronics has submitted its H-share issuance application to the China Securities Regulatory Commission, which has been accepted [7] - Lingrui Pharmaceutical's director plans to reduce his shareholding by up to 200,000 shares, representing 0.0353% of the total shares [8] - Jiahu Energy has adjusted its share repurchase price limit to 11.63 yuan per share [10] Group 4 - Spring Airlines reported a year-on-year increase of 12.23% in passenger turnover for August [11] - Kaida has received an invention patent for a self-calibrating sensor technology [12] - Chuanheng Co. has obtained a new utility model patent aimed at improving industrial waste utilization [14] Group 5 - Huashi Technology received a government subsidy of 2.21 million yuan, accounting for 22.71% of its latest audited net profit [15] - Shanghai Pharmaceuticals' controlling shareholder plans to increase its H-share holdings by up to 74 million shares [16] - Hongrun Construction has won a bid for a significant segment of the Shanghai Metro Line 21 project, valued at 126 million yuan [18] Group 6 - Sanfangxiang plans to invest 100 million yuan to establish a wholly-owned subsidiary focused on green technology [19] - Lao Fengxiang's subsidiaries plan to jointly invest in luxury goods sales and gold refining companies [20][21] - China Eastern Airlines reported an 8.72% year-on-year increase in passenger turnover for August [22] Group 7 - Inner Mongolia First Machinery has signed a railway freight car procurement contract worth 186 million yuan [22] - Jiuqiang Bio has received five invention patents related to diagnostic reagents [24] - Longmag Technology plans to invest 210 million yuan in its second phase project in Vietnam [25] Group 8 - Galaxy Magnetics plans to acquire 100% equity of Kyoto Longtai, with its stock suspended for trading [26] - Jinlong Co.'s controlling shareholder will have 30 million shares auctioned [27] - Haishi Co.'s controlling shareholder has released the pledge on 29.97 million shares [28] Group 9 - Qiu Tianwei plans to reduce its shareholding by up to 1.17% of the total shares [29] - Xiaocheng Technology's directors plan to reduce their shareholding by a total of 0.08% [30] - Victory Co. reported that Sunshine Life Insurance has reduced its shareholding by 4.4 million shares [31] Group 10 - Xindong Technology plans to distribute a cash dividend of 0.156 yuan per share [32] - Huaqin Technology plans to distribute a cash dividend of 0.13 yuan per share [33] - Kexing Pharmaceutical's controlling shareholder intends to transfer 5% of the company's shares [35] Group 11 - Guojin Securities has completed the repayment of its second short-term financing bond for 1.0205 billion yuan [38] - Chunhui Intelligent Control's application for asset acquisition has been accepted by the Shenzhen Stock Exchange [39] - Chaohongji has submitted its H-share issuance application to the Hong Kong Stock Exchange [40] Group 12 - Tianyue Advanced has fully exercised its over-allotment option, involving 716,180 H-shares [40] - Chengfeng Technology's vice president has resigned due to internal adjustments [41] - Yingpais plans to establish a 100 million yuan technology sports industry investment fund [43]

Core Viewpoint - The company, Siert (002538.SZ), announced that its chairman and general manager, Yuan Qirong, along with other executives, plan to increase their shareholdings in the company, indicating confidence in the company's future performance [1] Summary by Relevant Categories Shareholding Increase - Chairman and General Manager Yuan Qirong intends to increase his shareholding by an amount not less than RMB 3 million and not exceeding RMB 6 million [1] - Director and Deputy General Manager Yuan Peng plans to increase his shareholding by an amount not less than RMB 500,000 and not exceeding RMB 1 million [1] - Board Secretary Wu Changhao aims to increase his shareholding by an amount not less than RMB 250,000 and not exceeding RMB 500,000 [1]

Core Viewpoint - The company, Sierte (002538.SZ), announced that key executives plan to increase their shareholdings in the company, indicating confidence in its future performance [1] Group 1: Executive Share Purchases - Chairman and General Manager Yuan Qirong plans to purchase shares worth no less than RMB 3 million and no more than RMB 6 million [1] - Director and Deputy General Manager Yuan Peng intends to buy shares worth no less than RMB 500,000 and no more than RMB 1 million [1] - Board Secretary Wu Changhao aims to acquire shares worth no less than RMB 250,000 and no more than RMB 500,000 [1]

Group 1 - The company, Si Er Te, announced plans for share buybacks by key executives, including the chairman and general manager, with a total investment ranging from 300,000 to 600,000 RMB for the chairman and 50,000 to 100,000 RMB for the vice president [1] - The revenue composition for Si Er Te in the first half of 2025 shows that the chemical fertilizer manufacturing industry accounts for 88.14%, mining industry for 11.56%, and health sector for 0.3% [1] - The current market capitalization of Si Er Te is 4.4 billion RMB [2]

安徽省司尔特肥业股份有限公司公告 证券代码：002538 证券简称：司尔特 公告编号：2025-31 安徽省司尔特肥业股份有限公司 关于部分董事、高级管理人员增持公司股份的公告 本次增持人员保证向本公司提供的信息内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 1、增持主体：安徽省司尔特肥业股份有限公司（以下简称"公司"）董事长、 总经理袁其荣先生，董事、副总经理袁鹏先生，董事会秘书吴昌昊先生。 2、增持股份情况：上述人员将根据市场情况，计划自本公告披露之日起3 个月内通过集中竞价交易方式增持公司股份，董事长、总经理袁其荣先生拟增持 金额不低于人民币300万元，不超过人民币600万元（含）；董事、副总经理袁鹏 先生增持金额不低于人民币50万元，不超过人民币100万元（含）；董事会秘书 吴昌昊先生增持金额不低于人民币25万元，不超过人民币50万元（含）。 3、本次增持计划不设价格区间，将根据公司股票价格波动情况及资本市场 整体趋势实施增持计划。 公司近日收到了部分董事、高级管理人员发来的《股 ...

格隆汇9月15日丨司尔特（维权）(002538.SZ)公布，公司董事长、总经理袁其荣先生，董事、副总经理 袁鹏先生，董事会秘书吴昌昊先生将根据市场情况，计划自本公告披露之日起3个月内通过集中竞价交 易方式增持公司股份，董事长、总经理袁其荣先生拟增持金额不低于人民币300万元，不超过人民币600 万元（含）；董事、副总经理袁鹏先生增持金额不低于人民币50万元，不超过人民币100万元（含）； 董事会秘书吴昌昊先生增持金额不低于人民币25万元，不超过人民币50万元（含）。 ...

Core Viewpoint - The company Sier Te (002538.SZ) is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure, stemming from a prolonged embezzlement case involving its former financial director, which has created significant governance and financial reporting issues [1][2]. Group 1: Investigation and Governance Issues - The investigation was triggered by allegations against Huang Xili, the former financial director of the wholly-owned subsidiary Guizhou Lufang Industrial Co., who is suspected of embezzlement and has refused to cooperate with the investigation [1]. - Two directors, Wu Yuguang and Zhu Keliang, have expressed their inability to guarantee the authenticity and completeness of the company's financial reports due to the ongoing investigation and potential undisclosed fictitious transactions [2]. - The Anhui Securities Regulatory Bureau's inspection revealed that Guizhou Lufang had inflated costs through fictitious labor and engineering projects from 2021 to 2023, leading to inaccurate periodic reports [2]. Group 2: Financial Performance and Internal Control Failures - In the first half of 2025, the company reported a revenue increase of 7.15% to 2.183 billion yuan, but net profit plummeted by 43.6% to 95.18 million yuan, attributed to rising raw material costs [3]. - Concerns have been raised regarding the historical impact of fictitious business activities and the significant non-operational fund occupation by related parties, amounting to 176 million yuan, indicating a failure in internal controls [3]. - The company's situation reflects a typical path of internal control failure in A-share companies, characterized by subsidiary misconduct, executive cover-ups, ineffective auditing, and superficial rectification efforts, leading to a complete loss of trust [3].

Group 1 - The company, Sier Te, announced on September 12 that it and its controlling shareholders have not engaged in any form of stock price manipulation [2]